Hi guys,
Hopefully someone here will be able to help me out on this one.
Been reviewing the half yearly result and I am looking for information on why Resmed has gone to the effort of increasing their credit facility from ~300m to ~430m.
I understand that it is US debt and due to the quality of the companies balance sheet and earnings power that the interest rate is rock bottom low at 1.2%...but with the cash balance approaching $1bn what is the need for this?
Is this a case of getting the bankers on their side in case of future need?
Time to do a bit more digging...
tanking, page-18
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$38.40 |
Change
-0.190(0.49%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $38.40 | $38.58 | $38.30 | $19.94M | 518.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 906 | $38.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $38.49 | 313 | 1 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
